226 followers
Neurocognition is a promising biomarker to help distinguish CHR-P people, but evidence is lacking. This study aimed to identify differences in neurocognitive and overall functioning in adolescents with psychosis, CHR-P and non-CHR-P. https://t.co/XWkdIE9mx